- Home
- AUPH vs FLYW Comparison
AUPH vs FLYW Comparison
Compare AUPH & FLYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AUPH | FLYW |
|---|---|---|
| Founded | 1993 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.3B |
| IPO Year | 2014 | 2021 |
Fundamental Metrics
Financial Performance| Metric | AUPH | FLYW |
|---|---|---|
| Price | $16.29 | $18.79 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 14 |
| Target Price | ★ $17.25 | $16.21 |
| AVG Volume (30 Days) | 1.2M | ★ 2.0M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 5075.00 | 450.00 |
| EPS | ★ 0.53 | 0.03 |
| Revenue | $283,055,000.00 | ★ $623,025,000.00 |
| Revenue This Year | $17.54 | $19.68 |
| Revenue Next Year | $15.74 | $15.25 |
| P/E Ratio | ★ $31.08 | $623.33 |
| Revenue Growth | 20.38 | ★ 26.59 |
| 52 Week Low | $10.34 | $10.55 |
| 52 Week High | $19.25 | $19.73 |
Technical Indicators
Market Signals| Indicator | AUPH | FLYW |
|---|---|---|
| Relative Strength Index (RSI) | 54.99 | 56.42 |
| Support Level | $14.61 | $13.34 |
| Resistance Level | $16.46 | $18.94 |
| Average True Range (ATR) | 0.48 | 0.59 |
| MACD | 0.10 | 0.01 |
| Stochastic Oscillator | 50.68 | 62.11 |
Price Performance
Historical ComparisonAbout AUPH Aurinia Pharmaceuticals Inc
Aurinia Pharmaceuticals Inc is a biopharmaceutical company focused on delivering therapies to people living with autoimmune diseases with high unmet medical needs. The company developed LUPKYNIS (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis. It is also developing aritinercept, a dual inhibitor of B cell activating factor (BAFF) and a proliferation-inducing ligand (APRIL), for the potential treatment of autoimmune diseases.
About FLYW Flywire Corporation Voting
Flywire Corp provides a secure payment platform, offering its clients a streamlined process to receive reconciled domestic and international payments more cost-effectively and efficiently. The company's solutions are built on three core elements, namely a payments platform, a proprietary payment network, and vertical-specific software backed by its deep industry expertise. Geographically, the majority of revenue is from the Americas.